↓ Skip to main content
What is this page? Embed badge

Pediatric Cancer Therapeutics Development

Overview of attention for book
Cover of 'Pediatric Cancer Therapeutics Development'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 History of Drug Development for Children with Cancer
  3. Altmetric Badge
    Chapter 2 Targeted Small Molecule Drug Discovery
  4. Altmetric Badge
    Chapter 3 An FDA Oncology Perspective of Juvenile Toxicity Studies to Support Pediatric Drug Development
  5. Altmetric Badge
    Chapter 4 Design and Statistical Considerations for Early Phase Clinical Trials in Pediatric Oncology
  6. Altmetric Badge
    Chapter 5 Exploratory Clinical Development: From First in Humans to Phase 3 Ready
  7. Altmetric Badge
    Chapter 6 Gene and Cell Therapy: How to Build a BioDrug
  8. Altmetric Badge
    Chapter 7 The Pharma/Biotech Model for Drug Development: Implications for Pediatric Cancer Therapeutics
  9. Altmetric Badge
    Chapter 8 Clinical Research Organizations
  10. Altmetric Badge
    Chapter 9 Role of Patients and Advocates in Cancer Therapeutics Development
  11. Altmetric Badge
    Chapter 10 The Role of Regulatory Agencies in Pediatric Cancer Drug Development
  12. Altmetric Badge
    Chapter 11 Ethical Considerations in Pediatric Cancer Therapeutics Development
  13. Altmetric Badge
    Chapter 12 Future Directions
Attention for Chapter 11: Ethical Considerations in Pediatric Cancer Therapeutics Development
Altmetric Badge
Summary
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Ethical Considerations in Pediatric Cancer Therapeutics Development
Chapter number 11
Book title
Pediatric Cancer Therapeutics Development
Published by
Springer, Cham, January 2022
DOI 10.1007/978-3-031-06357-2_11
Book ISBNs
978-3-03-106356-5, 978-3-03-106357-2
Authors

Bhatnagar, Melanie E., Snyder, Donna L.

View on publisher site

This page is provided by Altmetric.